← Back to Home
Short Term·Markets Desk·Thu, 11 Jun
5 Short-Term Buys: ELECON, AUROPHARMA Backed by Research Desks
Research desks at Elitewealthltd and 3 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
By Markets Desk·11 Calls·11 Buy
Elitewealthltd and 3 other registered desks issued 11 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 11 buys against 0 sells — covering 5 stocks.
ELECON attracted 2 separate recommendations from registered analysts — Elitewealthltd issued a buy at ₹530 targeting ₹547 (stop ₹507); Elitewealthltd issued a buy at ₹530 targeting ₹560 (stop ₹507).
AUROPHARMA attracted 3 separate recommendations from registered analysts — Nifty issued a buy at ₹1,467.3 targeting ₹1,468; Nifty issued a buy at ₹1,467.3 targeting ₹1,468; Cnbc Awaaz issued a buy at ₹1,463 targeting ₹1,520 (stop ₹1,440).
SUDEEPPHRM attracted 3 separate recommendations from registered analysts — Zee Business issued a buy at ₹732 targeting ₹810; Zee Business issued a buy at ₹728 targeting ₹830; Zee Business issued a buy at ₹728 targeting ₹810.
Also covered: MEDANTA (₹1,229 → ₹1,400) via Zee Business; FINCABLES (₹1,028 → ₹1,200) via Zee Business.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
ElitewealthltdNiftyCnbc AwaazZee Business
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.